Imagerie moléculaire et radio-ligands dans le cancer du sein
Bulletin du Cancer · 2025
DOI: 10.1016/j.bulcan.2025.02.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bulletin du Cancer, 2025. Verfasst von Mathilde Masse und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service de médecine nucléaire, centre Antoine-Lacassagne, Nice, France; CNRS, Inserm, iBV, université Côte D'Azur, Nice, France. Electronic address: …. Hauptthemen laut MEDLINE: Breast Neoplasms, Molecular Imaging, Radiopharmaceuticals. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Molecular imaging plays a crucial role in the diagnosis, staging, and monitoring of breast cancer. The most commonly used tracer at present is 18F-FDG, a marker of cellular metabolism, making 18F-FDG PET/CT a major imaging modality in the management of breast neoplasms. However, this tracer has limitations, particularly for low-grade ductal or lobular neoplasms, which exhibit low avidity for 18F-FDG. The 68Ga-FAPI tracer, which targets activated fibroblasts and whose uptake is independent of tumor aggressiveness, is currently under investigation and could serve as an excellent alternative to 18F-FDG in certain cases. Additionally, new tracers targeting novel biological pathways of the tumor, including hormonal receptors or HER2, are being developed. These tracers enable whole-body assessment of specific biomarker expressions on cancer cells, offering a more precise understanding of the disease. This approach could help tailor treatments to the molecular characteristics of each tumor, enabling personalized strategies that improve therapeutic efficacy and patient quality of life. Finally, inspired by the model of 177Lu-PSMA used in prostate cancer, researchers are exploring the potential to couple these tracers with therapeutic agents to develop targeted radionuclide therapy for breast neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de médecine nucléaire, centre Antoine-Lacassagne, Nice, France; CNRS, Inserm, iBV, université Côte D'Azur, Nice, France. Electronic address: mathilde.masse@nice.unicancer.fr.
- Service d'oncologie, centre Antoine-Lacassagne, Nice, France.
- Service de médecine nucléaire, centre Antoine-Lacassagne, Nice, France; CNRS, Inserm, iBV, université Côte D'Azur, Nice, France.
Zitieren
APA
Masse, M., Bailleux, C., Creisson, A., & Humbert, O. (2025). Imagerie moléculaire et radio-ligands dans le cancer du sein. Bulletin du Cancer. https://doi.org/10.1016/j.bulcan.2025.02.014
Vancouver
Masse M, Bailleux C, Creisson A, Humbert O. Imagerie moléculaire et radio-ligands dans le cancer du sein. Bulletin du Cancer. 2025. doi:10.1016/j.bulcan.2025.02.014
BibTeX
@article{Masse2025,
author = {Masse, Mathilde and Bailleux, Caroline and Creisson, Anne and Humbert, Olivier},
title = {Imagerie moléculaire et radio-ligands dans le cancer du sein},
journal = {Bulletin du Cancer},
year = {2025},
doi = {10.1016/j.bulcan.2025.02.014}
}
EUVIMED